RE:RE:RE:FDA about TFC1067The only reason why FDA would ever come into play here on 1067, according to my own diligence, is if there was a requirement to market a "pharmaceutical strength" version that goes beyond the 0.4% concentration. At first I thought 0.4% was in fact a pharmaceutical grade but it may not be. The current 1067 agreement with Allergan is only for Cosmeceutical uses.
If we understood how No 35 made it on the FDA study list, that may give us a clue as to whom is up to what in this space. It could be AbbVie or even Sirona on their own, or someone else.